Why the study?
Do pharmacological interventions (aspirin, statins, beta blockers) reduce perioperative cardiac complications in patients undergoing non-cardiovascular surgery?
Do pharmacological interventions (aspirin, statins, beta blockers) reduce perioperative cardiac complications in patients undergoing non-cardiovascular surgery?
Aspirin and statins are strongly supported for perioperative cardioprotection in non-cardiovascular surgery, while beta blockers require careful titration due to adverse effects.
Supports aspirin and statin use perioperatively; leaves open optimal beta-blocker strategies pending randomized data.
Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no "magic bullet", pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients.
No takes yet. Share an insight, caveat, or question.
Leung et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: